| Kristin Danielle Hodge, MA CCC-SLP | |
|
1800 N Wabash Rd Ste 203, Marion, IN 46952-1300 | |
| (765) 651-3229 | |
| Not Available |
| Full Name | Kristin Danielle Hodge |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1800 N Wabash Rd Ste 203, Marion, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699038117 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 22005201A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Danielle Hodge, MA CCC-SLP Po Box 257, Sweetser, IN 46987-0257 Ph: (765) 618-2023 | Kristin Danielle Hodge, MA CCC-SLP 1800 N Wabash Rd Ste 203, Marion, IN 46952-1300 Ph: (765) 651-3229 |
News Archive
Compared with veteran doctors, recent medical school graduates are more likely to refer chronic kidney disease (CKD) patients for kidney transplantation before their patients require dialysis, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA.
A bacterial pathogen can communicate with yeast to block the development of drug-resistant yeast infections, say Irish scientists writing in the May issue of Microbiology. The research could be a step towards new strategies to prevent hospital-acquired infections associated with medical implants.
IMS Health today announced that John R. Walsh has been named senior vice president, Payer and Government Solutions, a new position. Previously, Walsh was senior vice president, Strategy and Business Development for IMS. He continues to report to David R. Carlucci, IMS chairman and CEO, and will be based in Norwalk, CT.
The Regenstrief Institute and Merck, known as MSD outside the United States and Canada, have signed a five-year agreement to collaborate on a range of projects that will use clinical data to inform personalized delivery of health care.
TxCell SA, a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today announces the signature of a strategic R&D collaboration agreement with the University of British Columbia (UBC) in Vancouver, Canada, a leading global center for multidisciplinary research and teaching.
› Verified 9 days ago
Amber Michelle Crane, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 N Wabash Rd, Ste. 203, Marion, IN 46952 Phone: 765-651-3229 Fax: 765-273-4369 | |
Katherine Downing Gibson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4725 S Colonial Oaks Dr, Marion, IN 46953 Phone: 765-674-2261 | |
Mrs. Dana Jane Blum, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2551 W Miami Trl, Marion, IN 46952 Phone: 765-664-9416 | |
Kelly Hall, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4725 S Colonial Oaks Dr, Marion, IN 46953 Phone: 765-674-9791 | |
Jessica Tinsley, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 N Wabash Ave., Suite 200, Marion, IN 46952 Phone: 765-651-3229 | |
Beth Ellen Krouse, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1800 Wabash Ave, Suite 200, Marion, IN 46952 Phone: 765-651-3229 | |
Robin Brady, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1320 W Spencer Ave, Marion, IN 46952 Phone: 765-662-0490 Fax: 765-662-0853 |